Fred Hutchinson
NCI-funded clinical trials add 14.2M life-years for patients with cancer over 4 decades
Clinical trials performed within the NCI’s National Clinical Trials Network during the past 40 years prolonged the lives of patients with cancer by at least 14.2 million life-years, according to a study in Journal of Clinical Oncology.
American Society for Transplantation and Cellular Therapy to present several awards
Several clinicians will be honored at this year’s Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR, scheduled for Feb. 15-19 in Orlando.
Study offers insights into COVID-19 vaccination, infection among HSCT recipients
NEW ORLEANS — Most hematopoietic stem cell transplant recipients received at least one dose of COVID-19 vaccine, according to single-institution study results presented at ASH Annual Meeting and Exposition.
Stem cell transplantation underutilized for acute myeloid leukemia
NEW ORLEANS — Utilization of hematopoietic stem cell transplantation for acute myeloid leukemia has increased over time but remains far below optimal levels, according to study results presented at ASH Annual Meeting and Exposition.
Experimental CAR-T safe, ‘highly effective’ for certain patients with T-cell malignancies
NEW ORLEANS — A novel chimeric antigen receptor T-cell therapy conferred a 78% complete response rate in patients with heavily pretreated T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma, study results showed.
Bispecific CAR-T induces response in blood cancers
Three-quarters of patients with advanced B-cell malignancies who received an investigational chimeric antigen receptor T-cell therapy achieved complete response, according to the agent’s manufacturer.
Patients with obesity ‘well-represented’ in cancer clinical trials
Patients with cancer and obesity appeared well-represented in clinical trials, indicating that clinical trial findings may be generalizable to this patient population, according to study results published in JAMA Network Open.
Medicaid expansion under ACA appears to improve cancer clinical trial access
CHICAGO — The Affordable Care Act’s expansion of Medicaid resulted in a nearly threefold increase in the percentage of patients using Medicaid in cancer trials by early 2020, according to study results presented during ASCO Annual Meeting.
Women at greater risk for more severe adverse events from cancer treatments
Women demonstrated a 34% increased risk for severe adverse events from any cancer treatment compared with men, according to a study published in Journal of Clinical Oncology.
Oncology Nursing Foundation announces mentorship award recipient
Kathleen Shannon Dorcy, PhD, RN, FAAN, received this year’s Connie Henke Yarbro Excellence in Cancer Nursing Mentorship Award.